FDA panel to focus on safety of Novartis gene therapy drug – Reuters UK
|
FDA panel to focus on safety of Novartis gene therapy drug
Reuters UK If approved, the drug would be first gene therapy to be approved in the United States. The FDA is not obliged to follow the recommendations of its advisors but typically does so. (Reporting by Toni Clarke in Washington; Editing by Nick Zieminski). |
